Press Releases July 22, 2026 08:00 AM

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors

Longtime Board Member Casey M. Tansey Retires from Inspire Medical Systems After 18 Years of Service

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
INSP

Inspire Medical Systems, a medical technology firm specializing in minimally invasive treatments for obstructive sleep apnea, announced the retirement of longtime board member Casey M. Tansey, effective July 30, 2026. Tansey has been instrumental since the company's founding and Series A financing in 2007. The company plans to appoint a new director soon.

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
INSP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Casey M. Tansey, an influential board member and early investor, is retiring after more than 18 years.
  • Tansey played a key role in Inspire’s founding, Series A financing, and ongoing growth.
  • Inspire Medical Systems focuses on innovative neurostimulation therapy for obstructive sleep apnea, approved by FDA and EU MDR.

MINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the retirement of Casey M. Tansey from the Inspire Board after more than eighteen years of service, effective July 30.

“We are thankful for the many contributions Mr. Tansey has made to our Board of Directors over the past eighteen years,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. “As one of the first venture investors to recognize the potential impact of Inspire therapy for patients with OSA, Mr. Tansey has provided valuable mentorship, leadership, and perspective throughout the Company’s founding, initial public offering and subsequent growth. We are grateful for his long-standing commitment and wish Mr. Tansey the very best in the future.”

Mr. Tansey represented U.S. Venture Partners, led Inspire’s Series A financing in November 2007 and has served on the Inspire Board of Directors since that time. The Company expects to announce the appointment of a new Director to replace Mr. Tansey in the near future.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA-, EU MDR- and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
[email protected]
617-549-2443


Risks

  • The departure of a long-standing board member may create temporary governance uncertainty.
  • Appointment of a new director could lead to shifts in board dynamics and strategic direction.
  • As a medical technology firm, regulatory approval and market adoption continue to pose ongoing business risks.

More from Press Releases

Sachem Capital Reports Third Quarter 2026 Results Nov 16, 2026 Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026